Not Rated
Fund Size
(0.09% of Investment in Category)
|
Expense Ratio
(2.09% Category average)
|
Period Invested for | ₹10000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
---|---|---|---|---|---|---|
No Data Found |
Period Invested for | ₹1000 SIP Started on | Investments | Latest Value | Absolute Returns | Annualised Returns |
---|---|---|---|---|---|
1 Year | 15-Oct-24 | 12000 | 12331.09 | 2.76 % | 5.16 % |
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.
Top 10 Stocks in Portfolio
Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
---|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd. | Pharmaceuticals | 605.8 | 13.05% | 0.07% | 17.91% (Mar 2025) | 12.98% (Aug 2025) | 3.80 L | 0.00 |
Max Healthcare Institute Ltd. | Hospital | 340 | 7.33% | -0.21% | 8.58% (Jun 2025) | 3.91% (Nov 2024) | 3.05 L | 0.00 |
J.b. Chemicals & Pharmaceuticals Ltd. | Pharmaceuticals | 275.3 | 5.93% | -0.02% | 5.95% (Aug 2025) | 3.34% (Oct 2024) | 1.61 L | 0.00 |
Cipla Ltd. | Pharmaceuticals | 255.6 | 5.51% | -0.28% | 7.08% (Oct 2024) | 4.81% (Jul 2025) | 1.70 L | 0.00 |
Divis Laboratories Ltd. | Pharmaceuticals | 227.6 | 4.90% | -0.35% | 6.09% (May 2025) | 4.83% (Jan 2025) | 40.00 k | 0.00 |
Apollo Hospitals Enterprises Ltd. | Hospital | 196.3 | 4.23% | -0.09% | 4.32% (Aug 2025) | 3.17% (May 2025) | 26.50 k | 0.00 |
Fortis Healthcare Ltd. | Hospital | 194 | 4.18% | 0.28% | 4.18% (Sep 2025) | 1.85% (Jan 2025) | 2.00 L | 0.00 |
Lupin Ltd. | Pharmaceuticals | 181.6 | 3.91% | 0.05% | 3.91% (Sep 2025) | 2.86% (Jul 2025) | 95.00 k | 0.00 |
Jubilant Life Sciences Ltd. | Pharmaceuticals | 151.1 | 3.26% | 0.19% | 4.18% (Oct 2024) | 3.04% (Apr 2025) | 1.40 L | 0.00 |
Krishna Institute of Medical Sciences Ltd. | Hospital | 140 | 3.02% | 0.69% | 3.02% (Sep 2025) | 2.01% (Oct 2024) | 2.00 L | 50.00 k |
Name | Type of Instrument | Weight (%) |
---|---|---|
TREPS | TREPS | 2.56% |
Net Receivables | Net Receivables | -0.24% |
Ratios calculated on daily returns for last 3 years (Updated as on 01st January, 1970)
No data available. Ratios are only available for the funds which are 3 years old.
Out of 120 mutual fund schemes offered by this AMC, 4 is/are ranked 4 * , 16 is/are ranked 3 * , 5 is/are ranked 2 * , 5 is/are ranked 1 * , and 90 schemes are not ranked. See more about AMC
Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
---|---|---|---|---|---|---|---|
Kotak Arbitrage Fund - Growth | 4 | 71517.53 | 0.48 | 1.29 | 2.78 | 6.56 | 7.17 |
Kotak Midcap Fund - Growth | 3 | 58299.59 | 1.27 | 1.73 | 18.89 | 1.72 | 23.01 |
Kotak Flexi Cap Fund - Growth | 4 | 54083.13 | 1.33 | 0.16 | 12.04 | 3.59 | 18.23 |
Kotak Money Market Fund - Growth | 3 | 32820.86 | 0.55 | 1.43 | 3.41 | 7.64 | 7.54 |
Kotak Liquid Fund - Regular Plan - Growth | 2 | 29473.72 | 0.48 | 1.41 | 3.00 | 6.72 | 6.96 |
Kotak Large & Midcap Fund - Growth | 3 | 28380.64 | 1.51 | 0.83 | 12.52 | -0.03 | 20.18 |
Kotak Multicap Fund - Regular Plan - Growth | 3 | 20284.98 | 2.55 | 3.37 | 14.37 | 0.43 | 24.56 |
Kotak Bond Short Term Plan - Growth | 4 | 18155.54 | 0.84 | 1.21 | 3.23 | 7.67 | 7.45 |
Kotak Corporate Bond Fund - Growth | 3 | 17545.56 | 0.96 | 1.42 | 3.61 | 8.23 | 7.93 |
Kotak Small Cap Fund - Growth | 2 | 17480.17 | -1.83 | -4.40 | 9.48 | -10.74 | 16.24 |